UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): March 31, 2018
AEON GLOBAL HEALTH CORP.
(Exact name of registrant as specified in its charter)
COMMISSION FILE NUMBER: 0-20190
|
DELAWARE |
14-1673067 |
|
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
|
2225 Centennial Drive |
|
Gainesville, GA 30504 |
|
(Address and zip code of principal executive offices) |
1-(888) 661-0225
(Registrant’s telephone number, including area code
|
___________________________________________ |
|
(Former Name, if Changed Since Last Report) |
|
CHECK THE APPROPRIATE BOX BELOW IF THE FORM 8-K FILING IS INTENDED TO SIMULTANEOUSLY SATISFY THE FILING OBLIGATION OF THE REGISTRANT UNDER ANY OF THE FOLLOWING PROVISIONS:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
|
Emerging growth company ☐ |
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ |
|
Item 3.02 |
Unregistered Sales of Equity Securities. |
The information disclosed in Item 5.02(e) of this Current Report on Form 8-K concerning the award of restricted stock units under the Aeon Global Health Corp. 2011 Omnibus Equity Incentive Plan, as amended, is incorporated by reference into this Item 3.02. The offers and sales of such securities have been determined to be exempt from registration under the Securities Act of 1933, as amended, in reliance on Section 4(a)(2) thereof. The issuance of the securities to the recipients were made without any form of general solicitation.
|
Item 5.02 |
Departure of Directors of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
(e) On March 31, 2018, the Company’s Board of Directors approved the grant of 40,724 restricted stock units to Mr. Hanif A. Roshan, the Company’s Chairman and Chief Executive Officer. In addition, the Board also approved the grant of an aggregate of 40,724 restricted stock units to certain other non-executive employees of the Company. All of the restricted stock units were granted under the Company’s 2011 Omnibus Equity Incentive Plan, as amended (the “2011 Plan”), and will vest on the one-year anniversary of the grant date. The Board determined that it was appropriate to grant the restricted stock units in consideration of an agreement by Mr. Roshan and the other non-executive employees to accept such compensation in lieu of cash payment of base salary for the five week period ending March 31, 2018.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
|
|
AUTHENTIDATE HOLDING CORP. |
|
|
|
|
|
|
|
By: /s/ Michael J. Poelking |
|
|
|
Name: Michael J. Poelking |
|
|
|
Title: Chief Financial Officer |
|
Date: April 3, 2018 |
|
3